Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting

Company's Chief Movement Officer, Arnold Schwarzenegger, Will Be Presidential Guest Speaker

ZBH : 97.97 (-1.53%)
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026

WARSAW, Ind. , Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment...

ZBH : 97.97 (-1.53%)
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

ZBH : 97.97 (-1.53%)
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

ZBH : 97.97 (-1.53%)
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution

Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance

ZBH : 97.97 (-1.53%)
The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call

The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call

ZBH : 97.97 (-1.53%)
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.

ZBH : 97.97 (-1.53%)
EW : 85.28 (-2.18%)
AZN : 201.76 (-0.97%)
Zimmer Biomet Stock: Is Wall Street Bullish or Bearish?

Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook.

ZBH : 97.97 (-1.53%)
$SPX : 6,816.63 (-0.94%)
IHI : 59.00 (-1.06%)
ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum

ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum

ZBH : 97.97 (-1.53%)
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations

Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations

ZBH : 97.97 (-1.53%)

Barchart Exclusives

3 Top Dividend Stocks To Buy In March
With market volatility rising, these three dividend payers could anchor your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar